Cargando…
Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification
One of the major features of prostate cancer (PCa) is its heterogeneity, which often leads to uncertainty in cancer diagnostics and unnecessary biopsies as well as overtreatment of the disease. Novel non-invasive tests using multiple biomarkers that can identify clinically high-risk cancer patients...
Autores principales: | Guo, Jinan, Liu, Dale, Zhang, Xuhui, Johnson, Heather, Feng, Xiaoyan, Zhang, Heqiu, Wu, Alan H. B., Chen, Lingwu, Fang, Jiequn, Xiao, Zhangang, Xiao, Kefeng, Persson, Jenny L., Zou, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758396/ https://www.ncbi.nlm.nih.gov/pubmed/33363151 http://dx.doi.org/10.3389/fcell.2020.597961 |
Ejemplares similares
-
A 23‐Gene Classifier urine test for prostate cancer prognosis
por: Guo, Jinan, et al.
Publicado: (2021) -
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
por: Guo, Jinan, et al.
Publicado: (2021) -
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
por: Johnson, Heather, et al.
Publicado: (2020) -
Genome-Wide Knockout Screen Identifies EGLN3 Involving in Ammonia Neurotoxicity
por: Li, Jiequn, et al.
Publicado: (2022) -
A Prognostic Model for Colon Cancer Patients Based on Eight Signature Autophagy Genes
por: Xu, Jiasheng, et al.
Publicado: (2020)